Clinical Trial Update: A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects [Phase 3]

View source ↗

Summary

This Phase 3 trial compares prasugrel with clopidogrel in patients with acute coronary syndrome. The study results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• EFFIENT (prasugrel hydrochloride)
• Plavix (clopidogrel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-05-07